Guangxi Liuzhou Pharm Co Ltd Net Asset Quality Index
Guangxi Liuzhou Pharm Co Ltd net asset quality index. Guangxi Liuzhou Pharm Co Ltd (603368) has a Net Asset Quality Index of 38.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥21.18 Billion minus total liabilities of CN¥13.05 Billion yields net assets of CN¥8.14 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Guangxi Liuzhou Pharm Co Ltd (603368) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Net asset quality index of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. This chart shows how Guangxi Liuzhou Pharm Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 38.4%, representing net assets of CN¥8.14 Billion against total assets of CN¥21.18 Billion CNY. See 603368 net asset value for net asset value and shareholders' equity analysis.
Guangxi Liuzhou Pharm Co Ltd Net Asset Quality Index by Year (2011–2024)
Guangxi Liuzhou Pharm Co Ltd net asset quality index by year from 2011 to 2024. The table below presents the year-by-year Net Asset Quality Index for Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Guangxi Liuzhou Pharm Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 37.3% | CN¥7.94 Billion | CN¥21.27 Billion | CN¥13.33 Billion | ▲ +2.3 pp |
| 2023 | 35.0% | CN¥7.06 Billion | CN¥20.16 Billion | CN¥13.10 Billion | ▲ +0.8 pp |
| 2022 | 34.2% | CN¥6.37 Billion | CN¥18.61 Billion | CN¥12.24 Billion | ▼ -2.4 pp |
| 2021 | 36.6% | CN¥5.81 Billion | CN¥15.87 Billion | CN¥10.07 Billion | ▼ -0.2 pp |
| 2020 | 36.8% | CN¥5.44 Billion | CN¥14.81 Billion | CN¥9.36 Billion | ▼ -2.2 pp |
| 2019 | 38.9% | CN¥4.66 Billion | CN¥11.96 Billion | CN¥7.30 Billion | ▼ -2.5 pp |
| 2018 | 41.4% | CN¥4.05 Billion | CN¥9.77 Billion | CN¥5.73 Billion | ▼ -5.8 pp |
| 2017 | 47.2% | CN¥3.57 Billion | CN¥7.55 Billion | CN¥3.99 Billion | ▼ -4.3 pp |
| 2016 | 51.6% | CN¥3.24 Billion | CN¥6.28 Billion | CN¥3.04 Billion | ▲ +20.0 pp |
| 2015 | 31.6% | CN¥1.36 Billion | CN¥4.30 Billion | CN¥2.94 Billion | ▲ +0.2 pp |
| 2014 | 31.4% | CN¥1.17 Billion | CN¥3.74 Billion | CN¥2.56 Billion | ▲ +12.9 pp |
| 2013 | 18.6% | CN¥501.00 Million | CN¥2.70 Billion | CN¥2.20 Billion | ▼ -0.1 pp |
| 2012 | 18.7% | CN¥378.59 Million | CN¥2.03 Billion | CN¥1.65 Billion | ▲ +1.2 pp |
| 2011 | 17.4% | CN¥274.23 Million | CN¥1.57 Billion | CN¥1.30 Billion | — |